Sort
15,842 grants matching “pancreatic cancer”
Bioinformatics Shared Resource
$206,642Jean-Pierre A Kocher · Mayo Clinic Rochester · P30 · FY2021 · CA
Bioinformatics Shared Resource
$206,642Jean-Pierre A Kocher · Mayo Clinic Rochester · P30 · FY2023 · CA
Role of Protein Kinase D in Pancreatic Cancer
$206,550Peter Storz · Mayo Clinic Jacksonville · R21 · FY2008 · CA
Dual recombinase models of pancreatic cancer
$206,516Elliott Scott Seeley · University Of California, San Francisco · R21 · FY2015 · CA
Core A: Administrative Core
$206,492William G Hawkins · Washington University · P50 · FY2024 · CA
Inflammatory processes In diet-Induced pancreatic cancer promotion
$206,488Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2014 · CA
Evaluation of a daily oral care lozenge on oral health and quality of life in older adults
$206,479Emily Ann Stein · Primal Therapies, Inc. · R43 · FY2017 · AG
Career Development Program
$206,433Donald J Buchsbaum · University Of Alabama At Birmingham · P50 · FY2014 · CA
Preclinical evaluation of a targeted Bmi1 inhibitor in pancreatic cancer
$206,431Kenneth P Olive · Columbia University Health Sciences · R21 · FY2014 · CA
Rational generation of a head and neck squamous cell cancer direct xenograft mode
$206,217Antonio Jimeno · University Of Colorado Denver · R21 · FY2010 · DE
Micro-western array methodology for assessment of preanalytical variability in bi
$206,190Barbara E Stranger · University Of Chicago · R21 · FY2016 · CA
Proteasome-mediated Degradation of Hematopoietic Progenitor Kinase 1 in Pancreati
$206,190Huamin Wang · University Of Tx Md Anderson Can Ctr · R21 · FY2011 · CA
Pancreatic cancer control by a novel combination treatment
$206,190Gerardo Guillermo Mackenzie · State University New York Stony Brook · R21 · FY2015 · CA
Targeting hyaluronan synthesis and signaling with BET inhibitors in pancreatic cancer
$206,190Krishan Kumar · Northwestern University At Chicago · R21 · FY2017 · CA
Conditional ablation of stellate cells to determine their role in pancreatitis an
$206,190Rosa F. Hwang · University Of Tx Md Anderson Can Ctr · R21 · FY2011 · CA
Mechanisms of Pancreatic Cancer Inhibition by SPARC
$206,190Susan L Cohn · University Of Chicago · R21 · FY2013 · CA
A Novel ROS Controlling Kinase
$206,190Eileen Anne Friedman · Upstate Medical University · R21 · FY2010 · CA
Two phospho-compounds for pancreatic cancer prevention
$206,190Gerardo Guillermo Mackenzie · State University New York Stony Brook · R21 · FY2015 · CA
Effectiveness of minocycline for reducing symptoms in pancreatic cancer patients
$206,190Xin Shelley Wang · University Of Tx Md Anderson Can Ctr · R21 · FY2012 · CA
Targeting cancer cachexia drivers using antibody-based approaches
$206,134Azeddine Atfi · Virginia Commonwealth University · R01 · FY2025 · CA
Defining the KRAS mutation specific interactions in pancreas cancer
$206,129Guy Hobbs · Medical University Of South Carolina · P20 · FY2022 · GM
Multi-Tracer PET/CT Imaging of Gemcitabine Response in Pancreatic Cancer
$206,117Dan J Kadrmas · University Of Utah · R21 · FY2014 · CA
Polyphenols Regulate Lipid Inflamm Processes in Pancreatic Cancer/Harris, Diane
$206,093Vay Liang W. Go · University Of California Los Angeles · P01 · FY2011 · AT
Novel Targeted Therapy in Pancreatic Cancer
$205,920Ravi Salgia · University Of Chicago · R21 · FY2010 · CA
Preclinical evaluation of NOS inhibitors for the treatment of pancreatic cancer
$205,920Christopher M Counter · Duke University · R21 · FY2010 · CA